Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 2
1989 3
1990 3
1994 1
1998 2
1999 1
2000 4
2001 11
2002 11
2003 11
2004 13
2005 16
2006 21
2007 16
2008 21
2009 19
2010 13
2011 23
2012 15
2013 16
2014 12
2015 15
2016 5
2017 3
2018 12
2019 7
2020 11
2021 7
2022 7
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

266 results
Results by year
Filters applied: . Clear all
Page 1
Bortezomib-induced peripheral neurotoxicity: an update.
Argyriou AA, Cavaletti G, Bruna J, Kyritsis AP, Kalofonos HP. Argyriou AA, et al. Among authors: kalofonos hp. Arch Toxicol. 2014 Sep;88(9):1669-79. doi: 10.1007/s00204-014-1316-5. Epub 2014 Jul 29. Arch Toxicol. 2014. PMID: 25069804 Review.
Molecularly targeted therapies for malignant gliomas.
Argyriou AA, Kalofonos HP. Argyriou AA, et al. Among authors: kalofonos hp. Mol Med. 2009 Mar-Apr;15(3-4):115-22. doi: 10.2119/molmed.2008.00123. Mol Med. 2009. PMID: 19148300 Free PMC article. Review.
Bevacizumab in the treatment of breast cancer.
Koutras AK, Fountzilas G, Makatsoris T, Peroukides S, Kalofonos HP. Koutras AK, et al. Among authors: kalofonos hp. Cancer Treat Rev. 2010 Feb;36(1):75-82. doi: 10.1016/j.ctrv.2009.10.007. Epub 2009 Nov 22. Cancer Treat Rev. 2010. PMID: 19932567 Review.
The Fire Within: NF-κB Involvement in Non-Small Cell Lung Cancer.
Dimitrakopoulos FD, Kottorou AE, Kalofonou M, Kalofonos HP. Dimitrakopoulos FD, et al. Among authors: kalofonos hp. Cancer Res. 2020 Oct 1;80(19):4025-4036. doi: 10.1158/0008-5472.CAN-19-3578. Epub 2020 Jul 2. Cancer Res. 2020. PMID: 32616502 Review.
Angiogenesis as a therapeutic target in breast cancer.
Koutras AK, Starakis I, Lymperatou D, Kalofonos HP. Koutras AK, et al. Among authors: kalofonos hp. Mini Rev Med Chem. 2012 Oct;12(12):1230-8. doi: 10.2174/138955712802761988. Mini Rev Med Chem. 2012. PMID: 22512568 Review.
Follicle-Stimulating Hormone Receptor (FSHR): A Promising Tool in Oncology?
Papadimitriou K, Kountourakis P, Kottorou AE, Antonacopoulou AG, Rolfo C, Peeters M, Kalofonos HP. Papadimitriou K, et al. Among authors: kalofonos hp. Mol Diagn Ther. 2016 Dec;20(6):523-530. doi: 10.1007/s40291-016-0218-z. Mol Diagn Ther. 2016. PMID: 27392476 Review.
A review on oxaliplatin-induced peripheral nerve damage.
Argyriou AA, Polychronopoulos P, Iconomou G, Chroni E, Kalofonos HP. Argyriou AA, et al. Among authors: kalofonos hp. Cancer Treat Rev. 2008 Jun;34(4):368-77. doi: 10.1016/j.ctrv.2008.01.003. Epub 2008 Feb 20. Cancer Treat Rev. 2008. PMID: 18281158 Review.
266 results